Julius Clinical - Crunchbase Company Profile & Funding

Q: Who invested in Julius Clinical?

Julius Clinical is funded by Ampersand Capital Partners.

Q: When was the last funding round for Julius Clinical?

Julius Clinical closed its last funding round on obfuscated from a Private Equity round.

Overview

Julius Clinical

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Julius Clinical

CB Rank

471707

Julius Clinical specializes in distinct therapeutic areas that offer a full-service proposal or separate functional service.

Founded

obfuscation

Private

Private Equity

Zeist, Utrecht, The Netherlands

101-250

www.juliusclinical.com

Health Care

Hospital

Pharmaceutical

Funding Rounds

Private Equity

OBF

obfuscation

Key People

Bassem Saleh: Chief Executive Officer
Past Role: TFS Trial Form Support, CEO
Erik van Zandbergen: Chief Commercial Officer
Past Role: NIZO, VP Clinical Research

Details

Legal Name

Julius Clinical Research B.V.

Operating Status

Active

Company Type

For Profit

Founders

Peter Schoevers

About the Company

Julius Clinical specializes in distinct therapeutic areas that offer a full-service proposal or separate functional service.

Phone Number

31 30 656 9900

Contact Email

info@juliusclinical.com

Predictions & Insights

Growth Insight

See this Growth Insight

Julius Clinical is

Lorem

to be growing

Top Contributing Factors

Market Share Expansion

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Neurological Diseases Clinical Trials

Conducts clinical trials focused on neurological diseases such as hearing loss, neurodegeneration, neuromuscular diseases, pain, and seizures.

Cardio-Metabolic and Renal Clinical Trials

Provides clinical trial services for cardio-metabolic and kidney diseases including chronic kidney disease, dyslipidemia, NASH, and type 2 diabetes.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Julius Clinical	1	obfuscated obfuscation	Ampersand Capital Partners	Private Equity
obfuscated obfuscation	Private Equity Round - Julius Clinical	1	obfuscated obfuscation	Ampersand Capital Partners	Private Equity
obfuscated obfuscation	Private Equity Round - Julius Clinical	1	obfuscated obfuscation	Ampersand Capital Partners	Private Equity
obfuscated obfuscation	Private Equity Round - Julius Clinical	1	obfuscated obfuscation	Ampersand Capital Partners	Private Equity
obfuscated obfuscation	Private Equity Round - Julius Clinical	1	obfuscated obfuscation	Ampersand Capital Partners	Private Equity

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Julius Clinical	1	obfuscated obfuscation	Ampersand Capital Partners	Private Equity
obfuscated obfuscation	Private Equity Round - Julius Clinical	1	obfuscated obfuscation	Ampersand Capital Partners	Private Equity
obfuscated obfuscation	Private Equity Round - Julius Clinical	1	obfuscated obfuscation	Ampersand Capital Partners	Private Equity
obfuscated obfuscation	Private Equity Round - Julius Clinical	1	obfuscated obfuscation	Ampersand Capital Partners	Private Equity
obfuscated obfuscation	Private Equity Round - Julius Clinical	1	obfuscated obfuscation	Ampersand Capital Partners	Private Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Ampersand Capital Partners	Yes	Private Equity Round - Julius Clinical	Hidde Van Kerckhoven
Ampersand Capital Partners	Yes	Private Equity Round - Julius Clinical	Hidde Van Kerckhoven
Ampersand Capital Partners	Yes	Private Equity Round - Julius Clinical	Hidde Van Kerckhoven
Ampersand Capital Partners	Yes	Private Equity Round - Julius Clinical	Hidde Van Kerckhoven
Ampersand Capital Partners	Yes	Private Equity Round - Julius Clinical	Hidde Van Kerckhoven